Traders should watch for potential downward pressure on KALV shares; consider this insider monetization a cautionary signal ahead of next earnings or clinical updates. Monitor for Form 4 filings indicating further sales or any offsetting buying.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 23 $15.56entry
- T+1 · 9mo ago +1.35%α +0.61% · $15.77
- T+5 · 9mo ago +3.21%α +2.59% · $16.06
- T+20 · 8mo ago +6.68%α +10.63% · $16.60
- T+60 · 6mo ago +71.98%α +63.73% · $26.76
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple C-suite executives at KalVista Pharmaceuticals (KALV) sold shares in a coordinated cluster over the past week, including the CEO, CFO, CMO, CDO, and CCO, realizing nearly $400K in total proceeds. The sales coincide with recent market activity showing insider selling pressure, raising concerns about near-term prospects despite no disclosed material events.
Key Financial Metrics
Key Facts
- CEO Palleiko sold $156,197 worth of shares, the largest individual sale in the cluster.
- All five C-suite executives participated in sales, totaling $396,600 in realized value.
- Concurrent with share sales, insiders also exercised stock options (marketed transactions, 'M') for 49,500 shares at $0 cost, indicating option monetization.
- No insider buying was observed, all activity was selling or option exercise.
- Recent 30-day insider activity shows continued selling pressure totaling $397K, consistent with this cluster.
Financial Impact
$396,600 in insider sales over 7 days, all from senior executives
Risk Factors
- Insider selling may signal lack of confidence in near-term catalysts or valuation.
- Market could interpret coordinated C-suite exits as negative, especially if no public explanation is provided.
- Exercised options may lead to incremental share dilution or sustained selling pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (13 trades, 7d window) | cluster-KALV-1771980287247 |
Track record
12 reports on KALV
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +4.15% at T+5 after the Apr 17, 2026 report. 3 of 5 went positive at some point.
Filters
- Jun 22, 202621w ago 15-12G Bearish 7/10 No price data
- Jun 17, 202621w ago EFFECT Neutral 3/10 Entry $27.00 No price data
- Jun 11, 202622w ago 8-K Neutral 5/10 Entry $26.99 No price data
- Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $27.00 No price data
- May 19, 202625w ago Insider Cluster Bearish 5/10 Entry $26.81 to $26.79 ▲ +0.07% +1.31% vs SPY
- May 19, 202625w ago Insider Cluster Neutral 2/10 Entry $26.81 to $26.79 ▼ −0.07% −1.31% vs SPY
- Apr 29, 202628w ago 8-K Bullish 8/10 Entry $26.67 to $26.71 ▲ +0.15% −2.96% vs SPY
- Apr 17, 202630w ago Insider Cluster Bearish 6/10 Entry $20.48 to $19.63 ▲ +4.15% +4.71% vs SPY
- Feb 23, 202638w ago Insider Cluster Bearish 6/10 Entry $15.56 to $16.06 ▼ −3.21% −2.59% vs SPY
- Feb 23, 202638w ago Insider Cluster Bearish 7/10 Viewing Entry $15.56 to $16.06 ▼ −3.21% −2.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers